You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ovarian

Showing 1 - 25 of 8,514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Shanghai Ovarian Cancer and Family Care Project

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      Shanghai first maternity and infant hospital
    Oct 31, 2023

    Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)

    Recruiting
    • Primary Ovarian Insufficiency
    • Premature Ovarian Failure
    • Toronto, Ontario, Canada
      Trio Fertility
    Oct 31, 2023

    Transforming Ovarian Cancer Diagnostic Pathways

    Not yet recruiting
    • Ovarian Cancer
      • Birmingham, United Kingdom
      • +2 more
      Nov 10, 2023

      Infertility Trial (duostim vs. two antagonist ovarian stimulations)

      Not yet recruiting
      • Infertility
      • duostim vs. two antagonist ovarian stimulations
      • (no location specified)
      Oct 17, 2023

      Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

      Not yet recruiting
      • Serous Ovarian Cancer
      • Advanced Ovarian Cancer
      • (no location specified)
      Sep 20, 2023

      IVF Trial in Bani Suwayf (Intra ovarian by platelet rich plasma)

      Not yet recruiting
      • IVF
      • Intra ovarian by platelet rich plasma
      • Banī Suwayf, Beni Suef, Egypt
        Beni-suef university Hospital
      Sep 16, 2023

      Epithelial Ovarian Cancer: A Retrospective Study

      Recruiting
      • Epithelial Ovarian Cancer
      • Hematologic features
      • Shanghai, Shanghai, China
        Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
      Oct 16, 2023

      Ovarian Cancer Trial in Helsinki (Biomolecular profiling)

      Recruiting
      • Ovarian Cancer
      • Biomolecular profiling
      • Helsinki, Finland
        Helsinki University and Helsinki University Hospital
      Nov 1, 2023

      Early Screening of Epithelial Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • Fragmentomics
      • (no location specified)
      Jun 26, 2023

      Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

      Not yet recruiting
      • Ovarian Cancer Recurrent
      • Fluzopril Combined With Apatinib
      • (no location specified)
      Oct 22, 2023

      Ovarian Cancer Trial in France (tests to determine HRD status)

      Not yet recruiting
      • Ovarian Cancer
      • tests to determine HRD status
      • Amiens, France
      • +3 more
      Nov 22, 2023

      Platinum-resistant Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • pegylated liposomal doxorubicin
      • (no location specified)
      Aug 2, 2023

      the Correlation Between Ovarian Function and Serum Biomarkers

      Recruiting
      • Premature Ovarian Insufficiency
      • +5 more
      • blood test
      • Beijing, China
        Dongzhimen Hospital, Beijing University of Chinese Medicine
      Oct 25, 2023

      Premature Ovarian Insufficiency, Diminished Ovarian Reserve Trial (EV-Pure™)

      Not yet recruiting
      • Premature Ovarian Insufficiency
      • Diminished Ovarian Reserve
      • (no location specified)
      Oct 2, 2023

      Metabolic Biomarkers and Their Prognostic Relationship in

      Not yet recruiting
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 24, 2023

      Relapsed Ovarian Cancer Trial (Fluzoparib, Apatinib)

      Not yet recruiting
      • Relapsed Ovarian Cancer
      • (no location specified)
      Oct 7, 2023

      Total Management of Ovarian Cancer

      Not yet recruiting
      • Tumor of Female Reproductive System
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 30, 2023

      Ovarian Cancer Trial in Roma (Blood sample)

      Recruiting
      • Ovarian Cancer
      • Blood sample
      • Roma, Italy
        Policlinico Universitario Agostino Gemelli
      Oct 10, 2023

      Participation Patterns Among Recurrent Ovarian Cancer Patients

      Not yet recruiting
      • Recurrent Ovarian Cancer
        • San Francisco, California
          Power Life Sciences
        Sep 30, 2023

        Diminished Ovarian Reserve Trial (oPRP)

        Not yet recruiting
        • Diminished Ovarian Reserve
        • oPRP
        • (no location specified)
        Mar 16, 2023

        Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

        Not yet recruiting
        • Ovarian Cancer Stage III
        • Ovarian Cancer Stage IV
        • Artificial Intelligence
        • (no location specified)
        Aug 24, 2023

        ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

        Recruiting
        • Ovarian Cancer Stage IV
        • Ovarian Cancer Stage III
          • Guangzhou, Guangdong, China
            Sun Yat-Sen Memorial Hospital
          Aug 30, 2023

          Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

          Active, not recruiting
          • Ovarian Cancer
          • Platinum-resistant Ovarian Cancer
          • Minsk, Belarus
            Minsk City Clinical Oncology Center
          Jul 27, 2023

          Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

          Not yet recruiting
          • Ovarian Cancer
          • Olaparib tablet
          • Pittsburgh, Pennsylvania
            UPMC Hillman Cancer Center
          Nov 1, 2023

          Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

          Not yet recruiting
          • Ovarian Cancer
          • +3 more
          • Toronto, Ontario, Canada
            Sunnybrook Research Institute
          Jul 18, 2023